ATE416257T1 - Promotoren für wachstums-differenzierungsfaktoren und deren verwendung - Google Patents

Promotoren für wachstums-differenzierungsfaktoren und deren verwendung

Info

Publication number
ATE416257T1
ATE416257T1 AT99941954T AT99941954T ATE416257T1 AT E416257 T1 ATE416257 T1 AT E416257T1 AT 99941954 T AT99941954 T AT 99941954T AT 99941954 T AT99941954 T AT 99941954T AT E416257 T1 ATE416257 T1 AT E416257T1
Authority
AT
Austria
Prior art keywords
promotors
differentiation factors
growth differentiation
gdf
promoters
Prior art date
Application number
AT99941954T
Other languages
English (en)
Inventor
Li-Fang Liang
Original Assignee
Metamorphix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metamorphix Inc filed Critical Metamorphix Inc
Application granted granted Critical
Publication of ATE416257T1 publication Critical patent/ATE416257T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99941954T 1998-07-15 1999-07-15 Promotoren für wachstums-differenzierungsfaktoren und deren verwendung ATE416257T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9286598P 1998-07-15 1998-07-15
US12327099P 1999-03-08 1999-03-08

Publications (1)

Publication Number Publication Date
ATE416257T1 true ATE416257T1 (de) 2008-12-15

Family

ID=26786143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941954T ATE416257T1 (de) 1998-07-15 1999-07-15 Promotoren für wachstums-differenzierungsfaktoren und deren verwendung

Country Status (10)

Country Link
US (2) US6555672B1 (de)
EP (1) EP1097233B1 (de)
JP (1) JP2002520043A (de)
AT (1) ATE416257T1 (de)
AU (1) AU5542799A (de)
CA (1) CA2333465C (de)
DE (1) DE69940022D1 (de)
DK (1) DK1097233T3 (de)
ES (1) ES2318900T3 (de)
WO (1) WO2000004051A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284882B1 (en) 1999-06-10 2001-09-04 Abbott Laboratories Myostatin gene promoter and inhibition of activation thereof
US6617440B1 (en) 1999-07-30 2003-09-09 Pfizer, Inc. Myostatin regulatory region, nucleotide sequence determination and methods for its use
DE60228710D1 (en) * 2001-07-11 2008-10-16 Ovita Ltd Bioassay für myostatin
US8460864B2 (en) 2003-01-21 2013-06-11 Ptc Therapeutics, Inc. Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US8426194B2 (en) 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
US9068234B2 (en) 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
CN101886075B (zh) * 2010-07-02 2011-12-21 东北农业大学 猪rosa26启动子及其应用
EP2970873A4 (de) * 2013-03-14 2017-02-22 President and Fellows of Harvard College Verfahren zur auswahl von mikroben aus einer genetisch modifizierten bibliothek zur detektion und optimierung der herstellung von metaboliten
ES2924479T3 (es) 2013-04-08 2022-10-07 Harvard College Composiciones para rejuvenecer las células madre del músculo esquelético
CA3010799A1 (en) 2016-01-06 2017-07-13 President And Fellows Of Harvard College Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
DK0690873T3 (da) * 1993-03-19 2003-09-29 Univ Johns Hopkins Med Vækstdifferentieringsfaktor-8
EP1095137A4 (de) * 1998-07-07 2002-05-22 Agres Ltd Neue promotorsequenzen des myostatingens
US6284882B1 (en) * 1999-06-10 2001-09-04 Abbott Laboratories Myostatin gene promoter and inhibition of activation thereof

Also Published As

Publication number Publication date
WO2000004051A3 (en) 2000-05-25
US20070161002A1 (en) 2007-07-12
HK1038572A1 (en) 2002-03-22
WO2000004051A9 (en) 2000-04-06
EP1097233B1 (de) 2008-12-03
JP2002520043A (ja) 2002-07-09
CA2333465C (en) 2007-07-03
ES2318900T3 (es) 2009-05-01
US6555672B1 (en) 2003-04-29
CA2333465A1 (en) 2000-01-27
WO2000004051A2 (en) 2000-01-27
AU5542799A (en) 2000-02-07
DK1097233T3 (da) 2009-03-23
EP1097233A2 (de) 2001-05-09
DE69940022D1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DE60230858D1 (de) Chemisch definiertes medium für kultivierte säugerzellen
ATE416257T1 (de) Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
CA2263725A1 (en) Immortalized cell lines for virus growth
ID21555A (id) Metoda untuk produksi gliserol oleh organisme-organisme yang direkombinasi
FI950628A0 (fi) Modifioidut sienisolut ja menetelmä rekombinanttituotteiden tuottamiseksi
ATE364620T1 (de) Amphotere sterole und deren verwendung
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
FI942625A0 (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
DE60232083D1 (de) Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten
AU1505700A (en) Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof
EP0787207A4 (de) Neue methode zum auffindenund bewerten biologisch aktiver moleküle
ATE414417T1 (de) Translations-kontrollelemente für proteinexpression mit hoher ausbeute in den plastiden von höheren pflanzen und verfahren zu deren verwendung
ATE236153T1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
NO954854D0 (no) Kulturmedietilsetningsstoffer for bioreaktorer
NO971567D0 (no) Fremgangsmåte for rensing av keratinocyttvekstfaktorer
TR200000483T2 (tr) Yabancı protein ifadesinin arttırılması için yöntem.
BR0008187A (pt) Controle biológico de nematódeos
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
DE122006000019I2 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
DE50003001D1 (de) Verwendung von porphyrinderivaten in aquarien
ATE317020T1 (de) Neues regulationssystem zur kontrolle der expression eines transgens
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
DE69104357D1 (de) Klonierungs- und/oder expressionsvektoren, verfahren zur ihrer herstellung und verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties